To All: I submit the following in response to some questions posed
here. PMTI held an investors meeting in Boston yesterday, and I
understand they had another scheduled in NYC today. The following
is not first hand info. I took it from AOL board from two members
who attended, and I believe to be reliable. (There have been many
rumors which I have seen posted and received in private e-mail and
believe to be false.)
The mood was bullish to say the least. NMS membership pending. Public
float 18M, daily vol 700k. No concern about delisting (one of the
rumors.)
Laser market objectives: Become dominant company with services in all
markets. Skin resurfacing($1-2B mkt), hair removal($2-3B), Tattoo &
other blemishes(.3B), tonsilectomy(.4B), burn diagnostics(.2B), etc.
They plan to continue to develop and acquire full suite of proprietary
lasers, have extensive distribution system, and are affiliated with
world class medical institutions. Only PMTI has full spectrum of
lasers. Sales and projections are as follows:
1. Skin resurfacing (Tissue technologies): over $20M/yr with backlog of
200 units at $50k each. Current orders 70-90 per Mo, Producing 50/M,
100/M within 3 months.
2. Hair removal(pending FDA approval): Over 500 inquiries from MD's,
sell for $125k, ability to produce 100/m by end of 96. With Canadian
orders, FDA approval not critical path until ~August.
3. Other lasers. Current sales 5M going to 30M this yr.
Total production (all lasers) 200/m by end of 96. Gross margins on
skin resurfacing laser are over 60%. Development of diode lasers as
"second generation" continues at Mass General. Much smaller (PC size)
than current (6ft h *4ft w).
Concerning FDA approval: "There have been no requests for additional
info and no irregularities." Tissue Tech acquisition should be
complete by end of week.
I will post more on electronic divisions later. They said a Hambrect
& Quest rep was there, and seemed impressed.
|
